FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.
What happened
FDA reviewed the Kleenhanz website (www.kleenhanz.com) and its Twitter page in April 2022; the site sends shoppers to retailers such as Amazon to buy the products. FDA found claims that the Kleenhanz Towelettes protect against coronavirus and kill HIV, hepatitis B and C, herpes, MRSA, E. coli and many other organisms. FDA said this makes the towelettes unapproved new drugs (a drug sold without the FDA approval the law requires) and misbranded drugs (labeled or promoted in ways that break the law).
What FDA found
The towelettes are sold as drugs to prevent or treat disease without an FDA-approved application.
Section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)The products are misbranded because they are nonprescription drugs that do not meet the requirements for marketing without an approved application.
Section 502(ee) of the FD&C Act, 21 U.S.C. § 352(ee)The website and Twitter posts claim the wipes prevent COVID-19 and other infections, which is evidence of intended drug use.
21 CFR 201.128The label names only benzalkonium chloride as the active ingredient, but the website says the wipes also contain benzethonium chloride, which is not allowed in consumer antiseptic hand rubs.
21 CFR 201.66(b)(2); 1994 Tentative Final MonographUsing more than one active ingredient does not match the monograph rules for consumer or health care antiseptics, so the products do not qualify for marketing without approval.
Section 505G(a)(3) of the FD&C Act, 21 U.S.C. § 355hShipping these unapproved, misbranded products between states is prohibited.
Sections 301(a) and (d) of the FD&C Act, 21 U.S.C. §§ 331(a) and (d)
What FDA wants
FDA tells the company to stop selling the unapproved products immediately, review all websites, labels and promotional material, and email COVID-19-Task-Force-CDER@fda.hhs.gov within 48 hours describing the steps taken and how repeat violations will be prevented, with supporting documents. If complete correction within 48 hours is not possible, the company must explain the delay and give a date.
Who should pay attention
- retailers and online marketplaces that list antiseptic wipes
- brands and contract manufacturers of hand sanitizer and antiseptic wipes
- e-commerce sellers whose product pages make germ- or disease-killing claims
This is a summary. Read the original letter on fda.gov.